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Oral squamous cell carcinoma (OSCC) is one of the most widely 
occurring cancers worldwide1 and is the eighth most common 
cancer in males throughout the world. However, it is not ranked 
among the top 10 cancers in females.1,2 Different populations 
show variable incidence and mortality rates for OSCC and it is 
generally more common in developing countries.1,3 
Standard treatments for these patients include surgery, 
chemotherapy, and radiotherapy. Despite the attempts for 
more efficient diagnosis and treatment of squamous cell carci- 
noma (SCC), 5-year survival of SCC patients in the past three 
decades remains around 50–60%.4 Advances in treatment of 
these patients requires adequate knowledge about the main 
mechanisms of tumorigenesis and spread of tumoral cells.Cul- 
ture of a cell line is one method for evaluation of tumor cell 
behavior in molecular level. HeLa cells isolated from tumors 
are highly valuable for biochemical and genetic research and 
evaluation of immunologic properties of cells. Homogeneity 
of the sample, numerous passages of cells, low cost, no ethical 
issues and more importantly, enabling the study of living cells 
are among the advantages of using these cell lines.5 
Several markers have been identified for assessment of the 
properties and confirmation of SCC cell line such as Sox2, 
Oct4, CD44, CD133, MDM2, P53, and vascular endothelial 
growth factor.6–11 
In general, tumor markers are divided into epithelial, con- 
nective tissue, and salivary gland types. Cytokeratins (CKs) are 
among the epithelial markers. As tumor markers, they have two 
main applications namely differentiating epithelial tumors from 
non-epithelial tumors and determining the type of epithelial 
tumor.12 CK is a filament-forming protein that provides struc- 
tural support for cells. In human epithelial cells, 20 subgroups of 
CKs are expressed and their type depends on the type of cell and 
location of CK in the cytoplasm.13 Several studies have assessed 
the expression of different types of CKs in OSCC cell lines.14,15 
CK8 has the widest range of expression in different types 
of epithelial and cancer cells among 20 types of CKs recog- 
nized so far.13 CK8 is expressed on the surface of carcinoma 
cells in mammals in contrast to normal epithelial cells.16,17 
Also, increased expression of CK8 has been reported in colon, 
pancreatic, breast, and lung cancer.18–20 
CK17 is a marker used for differentiation of basal cell layer 
in the epithelial complex. Its expression increases in laryngeal, 
pharyngeal, and lung cancer compared to normal tissue.21 
Studies on this topic have been mainly conducted in the 
United States and have mostly focused on isolation of pharyn- 
geal SCC cell line. Thus, this study aimed to assess the expres- 
sion level of CK8 and CK17 markers in three SCC cell lines to 
describe the molecular profile of OSCC cell lines. 
 
Materials and Methods 
This in vitro observational study was conducted on OSCC cell 
lines retrieved from the cell bank of Shahid Beheshti Univer- 
sity of Medical Sciences. The inclusion criterion was OSCC 
cell lines with a minimum of 45 passages. The exclusion cri- 
teria were poor quality of the specimen, no growth and prolif- 
eration in the culture medium and observing cell death under 
inverted microscope. The study protocol was approved in the 
ethics committee of our university. 
Three specimens of OSCC were evaluated in this study. 
The first specimen had been obtained from the mandibular 
right alveolar mucosa of a 59-year-old female diagnosed with 
moderately differentiated OSCC. The second specimen 
belonged to a 74-year-old female with a previous history   of 
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maxillary right alveolar mucosa OSCC with the diagnosis of 
recurrent well-differentiated SCC. The third specimen had 
been taken from the mandibular left gingiva of a 79-year-old 
male with the diagnosis of primary well-differentiated SCC. 
Cell Culture 
Specimens were cut into 2.5  2.5 cm2 pieces and placed under 
a biological hood for culture. The specimens were first rinsed 
with antibiotic solution containing penicillin, streptomycin, 
and amphotericin four times to decrease the risk of contamina- 
tion and increase the success of culture. The specimens were 
placed in capped dishes and minced by a scalpel. Enzyme solu- 
tion containing 0.08% type I collagenase was added and after 
3–5 min, the mixture was vibrated for 5 min. The mixture was 
then incubated for 30 min. The enzyme was then deactivated by 
complete culture medium containing 15% fetal bovine serum 
and centrifuged at 1,200 rpm for 5 min (C-28A; Boeco). The 
supernatant was discarded and 5 mL of culture medium 
(Dulbecco’s modified Eagle’s medium + Fungizone + antibiotic) 
was added to each of the four flasks. Using pipet filler, released 
cells in small flasks and unlysed cells in larger flasks were 
cultured and incubated (Thermo Scientific Heva Cell 150i). The 
culture media were evaluated daily and refreshed weekly. After 
24 days, cells were passaged for the first time. After 45 passages, 
cells were frozen and passaged again for 14 times. 
Designing CK8 and CK17 Primers and 
Reverse-Transcription Polymerase Chain Reaction 
RNA Extraction 
The cells were dissolved in 1 mL of Trizol, transferred into 
an Eppendorf tube and stored at room temperature for 5 min. 
For each 2 mL of the solution, 300 mL of chloroform was added 
to the mixture and stirred for 15 s followed by centrifugation at 
12,000 g at 4°C. After centrifugation, the superficial aqueous 
phase was transferred to a new microtube for RNA extraction. 
Isopropanol was added in the same volume as the solution to the 
microtube. The contents of the tube were mixed and stored on 
ice for 45 min followed by centrifugation at 12,000 g for 15 min 
at 4°C. The supernatant was discarded and 1 mL of 75% ethanol 
was added to the sediment. The mixture was centrifuged at 
7,500 g for 8 min at 4°C. The supernatant was discarded and the 
microtube containing the sediment was stored at room temper- 
ature for 10 min in order for the cell mass to dry. DNase con- 
taining DNase I (2 mL), DNase I (2 mL), RNase inhibitor (1 mL), 
and DEPC water 15 mL was added to the dried cell mass. 
The solution was incubated at 37C for 30 min. To inactivate 
DNase, 2 L of EDTA was added to the solution and incubated at 
65C for 10 min. The concentration of RNA was determined by 
a spectrophotometer and the RNA was stored at −70C. 
 
Synthesis of cDNA from the Extracted RNA 
For each 1 L of extracted RNA, 1 L of oligo DT primer 
and 10 L of deionized water were added. The ingredients 
were mixed and vortexed for a few seconds. The mixture in 
the microtube was stored at 70C for 5 min and was then 
immediately placed on ice. While placed on ice, the follow- 
ings were added to the microtube: 4 L of 5× reaction buffer, 
1 L of ribonuclease inhibitor and 2 L of 10 mM dNTP mix. 
The microtube was stored at 37C for 5 min. Next, 1 L of 
reverse transcriptase (200 U/L) was added and the micro- 
tube was placed in a thermocycler and heated as follows: 60 
min at 42C and 10 min at 70C. After completion of  cDNA 
synthesis in thermocycler, the tube containing cDNA was 
stored at 4C. 
 
Conduction of PCR 
First, CK8 and CK17 gene primers were designed as 
target genes using NCBI website and confirmed using BLAST. 
The sequence of these primers is presented in Table 1. 
The components of 25 L PCR reaction solution included 
100 ng genomic DNA, 1.5 pM/L MgCl2, 5 nM/L dNTPs, 2.5 
pM/L of each primer, 2.5 L of PCR buffer and one unit of Taq 
DNA polymerase.The PCR protocol included primary denatur- 
ation at 94C for 5 min, 32 cycles including 30 s at 94C, 1 min 
at 58C for CK8 (the temperature was 59C for CK19), 1 min 
at 72C and final elongation phase at 72C for 5 min. The PCR 
products were separated on agarose gel 2 containing SYBRsafe 
florescent dye and visualized with ethidium bromide staining. 
Data obtained from reverse-transcription polymerase chain 
reaction (RT-PCR) were expressed descriptively. 
Also, to further confirm the cell line, morphology of the 
cells was evaluated under an inverted microscope (TS100; 
Nikon, Tokyo, Japan). 
 
Results 
Culture of OSCC cells from all the three specimens was done 
successfully. Morphology of the cells was evaluated under an 
inverted microscope and it was found that the cultured cells 
had epithelial origin. 
After the conduction of RT-PCR, one specimen was 
excluded from the study due to poor quality of cell line. Figure 1 
shows electro-photograph of the results of RT-PCR of CK8 and 
CK17 genes. CK8 was expressed by all three cell lines. In the first 
specimen (moderately differentiated SCC), CK8 had a higher 
expression compared to that in the remaining two specimens. 
The expression of CK17 was observed in all three specimens as 
well. CK17 showed higher expression in the first and second 
specimens, which were more invasive than the third specimen. 
 
Table 1.  Sequence of CK8 and CK17 primers 
Primer Primer sequence 
CK8 Forward 5´-ATCGACATCGCCACCTACAG-3´ 
CK8 Reverse 5´-AGCTCAAACCACCCGCATAG-3´ 
CK17 Forward 5´-GAGAGGATGCCCACCTGACT-3´ 
CK17 Reverse 5´-TCCTCAGCGGGTGGTCTG-3´ 
 
 
Fig 1. Electron micrograph of the four primary specimens; S1: 
Moderately-differentiated SCC; S2: Recurrent well-differentiated SCC, 
S3: Primary well-differentiated SCC; S4: Excluded due to no regrowth. 
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Figures 2–4 show photomicrographs of the three cell lines 
at different time points after culture. 
 
Discussion 
By isolation of stem cells and recognition of the biology of 
normal and cancer cells, attempts were made to determine the 
behavior of tumors and find new treatment modalities based 
on cellular and molecular evidence. At first, studies were 
focused mainly on paraffin blocks of patients. However, due to 
differences with in vivo conditions, the results of these studies 
could not be generalized to the clinical setting to accurately 
reveal the actual behavior of tumors in vivo. Over time, cell 
proteins in paraffin blocks are degraded and this negatively 
affects the results of immunohistochemistry and PCR studies 
on these blocks. Thus, researchers tried to culture the cells. 
Since cancer cells are different from normal cells in growth and 
differentiation, they can be purified and used as immortal cell 
lines. These cells can be cultured for unlimited times and used 
for assessment of tumor behavior with no risk for patients.22 
The first studies on cell lines were started in 1960 in the 
United States.23 Since SCCs of the cervix and esophagus are 
more common than OSCC, the primary studies focused on cul- 
ture  of  SCC  cells  from  the  cervix.  After  5  years,   tissue 
specimens were obtained from patients with well-differentiated 
SCC of the cervix and successfully cultured. This cell line is cur- 
rently known as the HeLa cells. This cell line has been passaged 
close to 1 million times and has been confirmed.24–26In the next 
phase, emphasis was placed on cell line isolation from SCC of 
the pharynx, which resulted in extraction of three cell lines. 
Two cell lines were isolated in the United States from two well 
differentiated specimens known as HSCC1 and HSCC2 and are 
non-purchasable for cellular studies.27,28 The third cell line was 
extracted in Ireland from a well-differentiated SCC specimen 
commercially known as FADU, which can be purchased and 
this cell line has been extensively used for research purposes.29 
Well-differentiated SCC cell line has been used in all previous 
studies for cell culture since it is easy to culture and has a ten- 
dency for organization of cells next to each other resulting in 
faster stabilization of this cell line in culture medium. 
In the recent years, it has been confirmed that the clinical 
behavior of tumors with different grades is variable. Also, 
tumors are different in terms of potential for growth, destruc- 
tion and metastasis as well as tumor response to radiotherapy 
and chemotherapy. Thus, different cell lines are required for 
research purposes.30,31 
Inour study, in contrast toprevious studies, three completely 




Fig 2. Photomicrograph of OSCC1 (A) Four days after culture at 200× magnification; (B) four days after first trypsinization at 200× 
magnification; (C) final purified cell line at 400× magnification. 
 
 
Fig 3. Photomicrograph of OSCC2 (A) Four days after culture at 200× magnification; (B) four days after first trypsinization at 200× 
magnification; (C) final purified cell line at 400×. 
 
 
Fig 4. Photomicrograph of OSCC3 (A) Four days after culture at 200× magnification; (B) four days after first trypsinization at 200× 
magnification; (C) final purified cell line at 400×. 
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different grades and three distinct properties: First, the under- 
lying and confounding factors were standardized in the three 
specimens and equal culture conditions were provided for all the 
three. Second, none of the specimens had metastasis at the time 
of surgery and third, it was possible to compare growth pattern 
among the specimens. The proliferation rate of cells in culture 
medium was different from one another and followed the clin- 
ical pattern of tumor growth. Comparison of the three cultured 
specimens revealed that OSCC1 had moderate growth and dis- 
seminated growth pattern while OSCC2 (tumor  recurrence) 
had higher proliferation rate and more scattered growth pattern. 
The OSCC3 had lower proliferation rate than the other two and 
a more regular growth pattern. Comparison of the three speci- 
mens revealed that tumor grade had a direct association with 
growth pattern of cells in culture medium. On the other hand, it 
has been confirmed that tumor grade directly relates to prog- 
nosis and metastasis potential of tumor. Thus, it may be con- 
cluded that growth pattern of cells in the culture medium has a 
direct association with prognosis and metastasis. 
The PRMI culture medium is better than phosphate buff- 
ered saline for growth and proliferation of cells and enhances 
the culture conditions for cell proliferation especially in-be- 
tween passage of cells.4 
In our study, to register the cell line, we tried our best to use 
specific markers for epithelial cells. Thus, CK8 and CK17 cyto- 
keratin markers were used. One of these markers is for the super- 
ficial layer and the other one is for the basal layers of epithelium. 
Use of these markers enabled assessment of different epithelial 
layers. Nobusawa et al.32 showed strong expression of CK17 in 
moderate dysplasia and in situ carcinoma, which suggests that 
CK17 expression is a marker with high specificity for neoplastic 
changes. According to Escobar-Hoyos et al.33 CK17 has 94% sen- 
sitivity and 86% specificity for differentiation of OSSC from 
normal mucosa. Also, CK17 is correlated with poorer prognosis 
in SCC patients. There is a hypothesis that expression of CK17 in 
SCC affects stem cell properties of tumor and can be a predictor 
of treatment failure. In our study, increased expression of CK17 
was noted in the majority of SCCs, HSIL and immature meta- 
plasia while Kitamura et al.34 and Toyoshima et al.35 showed 
higher expression of CK17 in well-differentiated types of SCC. 
But, in our study expression of CK17 was equally higher in recur- 
rent well-differentiated and moderately-differentiated types. 
Expression of both CK8 and CK17 has been noted in car- 
cinoma of the cervix and their expression increases from 
normal tissue to invasive carcinoma. Both markers have high 
specificity for malignant transformation while their sensitivity 
is low. Also, CK8 can serve as a specific marker for malignant 
transformation in pre-invasive stage.12 However, Carrilho et 
al.36  reported  increased  expression  of  CK8  and  CK17  in 
invasive carcinomas. Martens et al.37 showed that CK8 alone or 
in combination with CK17 can confirm higher invasion. 
Brotherick et al.38 demonstrated high expression of CK8 in 
metastatic SCC. Since in our study expression of CK8 was 
higher in moderately differentiated SCC specimen compared 
to the other two well-differentiated types, our results con- 
firmed the findings of previous studies. 
Cells obtained in our study can serve as a source for 
studies on treatment of different head and neck cancers par- 
ticularly OSCC. Studies on the efficacy of drugs and treatment 
modalities require large volume of cells, which may not be 
obtained from tissue specimens. By isolation and purification 
of these cells, an unlimited cell source can be achieved. On the 
other hand, by purifying these cells, their pure response to 
treatment protocols can be identified because several parame- 
ters related to tissues, such as cells and their secretions can 
interfere with the treatment protocol as a confounder and 
affect the results. Studies on cell lines are useful for treatment 
of cancer and assessment of tumor behavior. 
Two out of three isolated cells were cultured for the first 
time in Iran. RT-PCR was also performed to confirm the cell 
lines had epithelial origin. Future studies are required for 
immunohistochemical assessment of isolated cells. Also, 
immortalization of the cells should be performed to introduce 
them as cell lines. This study was a preliminary study to pave 
the way for evidence-based introduction of new treatment 
protocols to improve prognosis of OSCC patients. 
 
Conclusion 
Considering the expression of CK8 and CK17 in superficial 
and basal layer of epithelium in our three specimens and the 
differences in their expression based on the malignancy grade, 
these markers can be used as epithelial specific markers with 
more specificity in malignancies. Also, cells obtained from this 
study can be a reliable source for researches in the field of head 
and neck cancers, especially OSCCs to introduce cell lines. 
This study can be a basis for further cancer research and 
designing new treatments. 
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